Krishna Institute of Medical Sciences Limited

KIMSNotably above fair value

A 6-pillar fundamental profile. Each pillar scored 0–10.

6.0/10 composite
Prism for KIMS.NS: composite 6.0 of 10, verdict Notably above fair valuePULSEQUALITYMOATSAFETYGROWTHVALUE9.35.16.54.07.4Below cohort range—

Pulse

9.3 · Positive

Analyst revision trend (fallback)

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means more positive near-term tailwinds.

Quality

5.1 · Moderate

Piotroski 5/9, ROCE 13.2%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

6.5 · Moderate

Narrow moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

4.0 · Weak

D/E 1.89, Int cov 7.3x

Safety looks at balance-sheet quality, leverage, and cash generation. Higher means lower financial risk.

Growth

7.4 · Moderate

Rev CAGR 13.3%, EPS CAGR 13.9%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

— · Insufficient peer data

Only 0 MoS peers in cohort

Value measures how the stock's price compares to its intrinsic worth. Higher means more discount to fair value.

Compare with another stock

Overlay KIMS's prism against a peer.

Share this prism

Share on XWhatsApp

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for KIMS.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.